Table 3 Numerous physicochemical, ADMET, drug-likeness, and pharmacological properties of the compound BPU, estimated and predicted via the SwissADME server.

From: Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies

Property

Estimate/Prediction

Formula

C13H10BrF3N4O

MW

375.14

#Heavy atoms

22

#Aromatic heavy atoms

12

#Rotatable bonds

5

#H-bond acceptors

6

#H-bond donors

1

MR (molar refractivity)

76.72

TPSA (Å2)

72.11

Consensus Log Po/w

2.72

Ali class

Soluble

Log S (SILICOS-IT)

− 5.18

SILICOS-IT class

Moderately soluble

Log Kp (skin permeation; cm/s)

− 6.95

Lipinski #violations

0

Bioavailability score

0.55

GPCR (G protein-coupled receptor) ligand

0.31

Ion channel modulator

0.46

Kinase inhibitor

0.71

Nuclear receptor ligand

0.12

Protease inhibitor

0.19

Enzyme inhibitor

0.34